GOSS · Gossamer Bio, Inc. · Executive Compensation
$0.16
0.00 (-2.63%)
At close · Sep 10
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company's existing cash and cash equivalents are not sufficient to fund operating plans for at least one year from the issuance date of these financial statements. Accordingly, these conditions raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$78.31M
Shares
488.85M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Faheem Hasnain | Chairman, President and Chief Executive Officer | $2,300,455 |
| Bryan Giraudo | Chief Operating Officer and Financial Officer | $1,253,431 |
| Robert Smith | — | $1,180,744 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Faheem Hasnain | Chairman, President and Chief Executive Officer | $2,005,432 |
| Bryan Giraudo | Chief Operating Officer and Financial Officer | $1,171,904 |
| Richard Aranda | Chief Medical Officer | $1,065,055 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Faheem Hasnain | Chairman, President and Chief Executive Officer | $2,095,988 |
| Robert Smith | — | $1,330,845 |
| Bryan Giraudo | Chief Operating Officer and Financial Officer | $1,287,882 |
| Richard Aranda | Chief Medical Officer | $1,032,753 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Faheem Hasnain | Chairman, President and Chief Executive Officer | $7,262,410 |
| Bryan Giraudo | Chief Operating Officer and Financial Officer | $3,268,699 |
| Richard Aranda | Chief Medical Officer | $2,481,944 |
| Chief Commercial | Officer | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Faheem Hasnain | Chairman, President and Chief Executive Officer | $4,751,620 |
| Bryan Giraudo | Chief Operating Officer and Financial Officer | $2,825,437 |
| Christian Waage | Executive Vice President, Technical Operations and Administration | $1,650,988 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Sheila Gujrathi | Former President and Chief Executive Officer | $7,213,742 |
| Bryan Giraudo | Chief Operating Officer and Financial Officer | $2,014,958 |
| Luisa Salter-Cid | — | $1,994,828 |
| Christian Waage | Executive Vice President, Technical Operations and Administration | $1,990,351 |
| Jakob Dupont | Former Chief Medical Officer | $1,642,287 |
| Faheem Hasnain | Chairman, President and Chief Executive Officer | $598,771 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Sheila Gujrathi | Former President and Chief Executive Officer | $6,245,606 |
| Bryan Giraudo | Chief Operating Officer and Financial Officer | $2,647,282 |
| Luisa Salter-Cid | — | $2,258,884 |
| Chief Scientific | Officer | $2,258,884 |
| Christian Waage | Executive Vice President, Technical Operations and Administration | $2,060,653 |
| Jakob Dupont | Former Chief Medical Officer | $1,637,440 |
| Faheem Hasnain | Chairman, President and Chief Executive Officer | $982,222 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Faheem Hasnain | Chairman, President and Chief Executive Officer | $18,709,912 |
| Sheila Gujrathi | Former President and Chief Executive Officer | $18,709,912 |
| Jakob Dupont | Former Chief Medical Officer | $3,530,454 |
| Bryan Giraudo | Chief Financial Officer | $2,192,515 |
| Chief Scientific | Officer | $1,858,327 |
| Christian Waage | Executive Vice President and General Counsel | $867,304 |